We are live on ! Find out more
LAB icon

Standard BioTools
LAB

79 hedge funds and large institutions have $291M invested in Standard BioTools in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 23

35% more call options, than puts

Call options by funds: $1.41M | Put options by funds: $1.04M

28% more capital invested

Capital invested by funds: $227M → $291M (+$64.3M)

1.46% more ownership

Funds ownership: 97.77% → 99.23% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 84 → 79 (-5)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
79
Holders Change
-5
Holders Change %
-5.95%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
34
Reduced
23
Closed
11
Calls
$1.41M
Puts
$1.04M
Net Calls
+$366K
Net Calls Change
+$308K

Top Buyers

Rank Fund Capital Flow
1
ECM
Endurant Capital Management
California
+$3.19M
2
PVI
Pura Vida Investments
New York
+$1.6M
3
SSA
Schonfeld Strategic Advisors
New York
+$891K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$866K
5
Renaissance Technologies
Renaissance Technologies
New York
+$585K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$3.6M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$863K
3
Jennison Associates
Jennison Associates
New York
-$410K
4
PP
Paloma Partners
Connecticut
-$339K
5
BlackRock
BlackRock
New York
-$276K
Name Holding Trade Value Shares
Change 		Change in
Stake
MFW
76
Mosaic Family Wealth
Missouri
$5K – – –
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
$4.37K -$1.52K -214 -27%
Royal Bank of Canada
78
Royal Bank of Canada
Ontario, Canada
$4K +$3.87K +544 +3,022%
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
$1K -$28 -4 -2%
Jennison Associates
80
Jennison Associates
New York
– -$410K -68,791 Closed
PP
81
Paloma Partners
Connecticut
– -$339K -56,900 Closed
Susquehanna International Group
82
Susquehanna International Group
Pennsylvania
– -$256K -35,958 Closed
Squarepoint
83
Squarepoint
New York
– -$148K -24,795 Closed
LP
84
LMR Partners
United Kingdom
– -$144K -24,169 Closed
VF
85
Virtu Financial
New York
– -$76K -12,784 Closed
TI
86
Trexquant Investment
Connecticut
– -$71K -11,857 Closed
TPWA
87
TRUE Private Wealth Advisors
Oregon
– -$59K -10,000 Closed
CF
88
Centaurus Financial
California
– -$9K -1,500 Closed
Fifth Third Bancorp
89
Fifth Third Bancorp
Ohio
– -$3K -516 Closed
PIA
90
Piedmont Investment Advisors
North Carolina
– -$3K -456 Closed
1 2 3
4

LAB Hedge Fund Activity: Q3 2018 in Review

79 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2018, worth a combined $291M — up 28% from $227M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of LAB and 6 opened new positions — a net loss of 5 holders — while 23 trimmed existing stakes and 34 added.

The largest buyer was Endurant Capital Management, adding an estimated $3.19M. The largest seller was OrbiMed, cutting an estimated $3.6M.

  • 79 institutional investors held Standard BioTools (LAB) as of Q3 2018, down from 84 in Q2 2018.
  • Funds reported $291M of Standard BioTools stock for Q3 2018, up 28% quarter-over-quarter.
  • 6 funds opened new Standard BioTools positions in Q3 2018 and 11 closed out, a net change of -5 holders.
  • The largest Standard BioTools buyer in Q3 2018 was Endurant Capital Management, an estimated $3.19M added.
  • The largest Standard BioTools seller in Q3 2018 was OrbiMed, an estimated $3.6M sold.

Based on aggregated 13F filings for Q3 2018.